featured
Second-Look Surgery Plus Hyperthermic Intraperitoneal Chemotherapy vs Surveillance in Patients at High Risk of Developing Colorectal Peritoneal Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Second-Look Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Versus Surveillance in Patients at High Risk of Developing Colorectal Peritoneal Metastases (PROPHYLOCHIP-PRODIGE 15): A Randomised, Phase 3 Study
Lancet Oncol 2020 Jul 24;[EPub Ahead of Print], D Goéré, O Glehen, F Quenet, JM Guilloit, JM Bereder, G Lorimier, E Thibaudeau, L Ghouti, A Pinto, JJ Tuech, R Kianmanesh, M Carretier, F Marchal, C Arvieux, C Brigand, P Meeus, P Rat, S Durand-Fontanier, P Mariani, Z Lakkis, V Loi, N Pirro, C Sabbagh, M Texier, D EliasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.